A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting customers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Express Worries
However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to users injecting substances of uncertain source.
Several professionals said the popularity for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.
Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or imprisonment.
Platform Response and Content Removal
Based on TikTok, the platform has taken down problematic content and prohibited associated hashtags and query recommendations. The organization stated it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also discovered communities with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, glowing reviews and detailed guides for mixing or injecting at home.
Within minutes of entering one community, a seller shared WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and promised delivery within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.
Item Information and Pricing
Inside these communities, posts show black plastic parcels with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram stated it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering substances they can’t verify. Although the science behind retatrutide is valid, these digital versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has already encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”
Producer Statement
A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to possibly significant health risks”.
